Free Trial

PowerUp Acquisition (PWUPW) Competitors

$0.04 -0.01 (-18.18%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PWUPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

PowerUp Acquisition vs.

180 Life Sciences (NASDAQ:ATNFW) and PowerUp Acquisition (NASDAQ:PWUPW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, community ranking, earnings, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
PowerUp Acquisition N/A N/A N/A

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat PowerUp Acquisition's score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
PowerUp Acquisition Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
PowerUp AcquisitionN/AN/AN/AN/AN/A

180 Life Sciences and PowerUp Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
PowerUp AcquisitionN/AN/A

Summary

180 Life Sciences beats PowerUp Acquisition on 1 of the 1 factors compared between the two stocks.

Get PowerUp Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for PWUPW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PWUPW vs. The Competition

MetricPowerUp AcquisitionShell Companies IndustryFinancial SectorNASDAQ Exchange
Market CapN/A$49.98M$3.90B$9.14B
Dividend YieldN/A5.35%4.44%3.98%
P/E RatioN/A38.28434.8717.66
Price / SalesN/A864.952,113.1281.09
Price / CashN/A178.7352.8637.71
Price / BookN/A22.211.914.73
Net IncomeN/A-$537,777.78$440.80M$225.42M
7 Day PerformanceN/A-0.03%0.93%-0.44%
1 Month PerformanceN/A-0.23%4.13%3.57%
1 Year PerformanceN/A6.14%14.93%19.20%

PowerUp Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PWUPW
PowerUp Acquisition
N/A$0.05
-18.2%
N/A-6.1%$0.00N/A0.00N/APositive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+73.1%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-1.0%
N/A-30.0%$0.00N/A0.002
AIMDW
Ainos
N/A$0.15
+51.5%
N/A+156.2%$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$2.81
-1.1%
N/A-28.5%$0.00$391.87M0.004Short Interest ↓
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
flat
N/A+39.1%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.06
-1.1%
N/A+689.5%$0.00$35.36M0.0070
BTMDW
biote
N/A$0.44
-11.2%
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.14
+0.7%
N/A-90.6%$0.00N/A0.008Short Interest ↑
CELUW
Celularity
N/A$0.06
+0.3%
N/A+167.9%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:PWUPW) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners